Medical University is studying prevalence and risk factors of SARS-CoV-2 in the Upper Silesian Agglomeration

Photo by Macau Photo Agency

Medical University of Silesia (Poland) is starting a new clinical trial of Prevalence and Risk Factors of SARS-CoV-2 in the Upper Silesian Agglomeration.

Project is designed as a comprehensive population-based epidemiological study in Upper-Silesian Conurbation (Poland) aiming at analysis of available data on incidence and mortality due to COVID-19 and estimation of the occurrence of viral infection SARS-CoV-2 as revealed by the results of serological test (ELISA: IgM, IgG), with assessment of risk factors.

The project's objectives are:
- to assess incidence and mortality due COVID-19 according to sex, age and coexisting diseases;
-to determine the level of potential "underdiagnosis" of the magnitude of COVID-19 mortality using vital statistics data for Upper-Silesian Conurbation;
- to assess the prevalence of SARS-CoV-2 based on the level of seropositivity in Upper-Silesian Conurbation;
-to identify host-related and environmental risk factors if the infection. Analysis of existing data will include monthly records on incidence and mortality over the period 01.01.2020-31.12.2020 and comparison of the findings with the monthly records of 2018 and 2019, for the same population.
Cross-sectional epidemiological study will be located in three towne (Katowice, Sosnowiec, Gliwice).
The project corresponds with analogous population-based studies on COVID-19 in a number of countries and responds to the WHO recommendation in that field.

Study population of this clinical trial are patients selected by random inhabitants of one of three towns (Katowice, Sosnowiec, Gliwice) with no age limits.

The clinical trial started on June 22, 2020 and will continue throughout April 22, 2021.

The contacts and locations are the Diagnostyka sp zoo, Katowice, Poland.

For more details: https://ichgcp.net/clinical-trials-registry/NCT04627623.